ClinicalTrials.Veeva

Menu

TGFB1 And LAMA1 Gene Polymorphisms in High Myopia

E

Ege University

Status

Completed

Conditions

High Myopia
Gene Mutations

Treatments

Genetic: TGFB1 AND LAMA1 GENE POLYMORPHISMS

Study type

Interventional

Funder types

Other

Identifiers

NCT03451877
2013-TIP-097

Details and patient eligibility

About

The investigators aimed to investigate TGFB1 and LAMA1 gene polymorphisms in children with high myopia in order to determine the genetic basis of large myopic shifts causing severe visual impairment and complications.

Seventy-four children with high myopia (≥6 diopters [D]; study group) and 77 emmetropic children (±0.5D; control group) were included. Genetic and polymorphism analyses were performed in the Medical Genetics Laboratory using DNA purified from the patients' blood samples.

Enrollment

151 patients

Sex

All

Ages

3 to 13 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients under the age of 13
  • Patients with cycloplegic refraction values ≥6 D (for study group)
  • Emmetropic patients (for control group)

Exclusion criteria

  • Patients who had additional ocular pathology that may affect refraction (such as glaucoma, cataracts, corneal disease)
  • Patients with history of ocular surgery

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

151 participants in 2 patient groups

Study group
Active Comparator group
Description:
Children with cycloplegia refractive error more than -6 D TGFB1 AND LAMA1 GENE POLYMORPHISMS were examined
Treatment:
Genetic: TGFB1 AND LAMA1 GENE POLYMORPHISMS
Control group
Other group
Description:
Emmetropic children TGFB1 AND LAMA1 GENE POLYMORPHISMS were examined
Treatment:
Genetic: TGFB1 AND LAMA1 GENE POLYMORPHISMS

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems